Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Testosterone's muscle-building effects do not require its conversion to DHT.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Finasteride for hair loss has minimal impact on sexual function.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

Finasteride doesn't reduce sexual function in people with hair loss.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Testosterone levels are not linked to erectile dysfunction in young and middle-aged men with HIV.

Finasteride doesn't affect erections much, but may decrease libido in men.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride doesn't negatively affect sexual function in Indian men with hair loss.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.